Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Probiotics: "living drugs".

G W Elmer1

  • 1Medicinal Chemistry, School of Pharmacy, University of Washington, Box 357610, Seattle, WA 98195, USA. elmer@u.washington.edu

American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|July 14, 2001
PubMed
Summary

Probiotics, live microorganisms, can prevent and treat infections like diarrhea and vaginal infections by improving microbial balance. While generally safe, caution is advised for immunocompromised patients, with more research needed on their full efficacy and safety.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Does gastrointestinal Candida albicans prevent ubiquinone absorption?

Medical hypotheses·2001
Same author

Possible interaction between warfarin and Lycium barbarum L.

The Annals of pharmacotherapy·2001
Same author

Biotherapeutic agents in the treatment of infectious diarrhea.

Gastroenterology clinics of North America·2001
Same author

The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2000
Same author

Antibiotics and Clostridium difficile diarrhea in the ambulatory care setting.

Clinical therapeutics·2000
Same author

Behaviour of Saccharomyces boulardii in recurrent Clostridium difficile disease patients.

Alimentary pharmacology & therapeutics·1999

Area of Science:

  • Microbiology
  • Gastroenterology
  • Infectious Diseases

Background:

  • Probiotics are live microorganisms administered to enhance microbial balance, particularly in the gastrointestinal and vaginal tracts.
  • Specific strains like Saccharomyces boulardii and Lactobacillus rhamnosus GG show efficacy in preventing antimicrobial-associated diarrhea.
  • Other gastrointestinal and vaginal infections are also being studied for probiotic interventions.

Purpose of the Study:

  • To discuss the uses, mechanisms of action, and safety of probiotics.
  • To review clinical evidence for probiotic efficacy in various infections.
  • To explore potential mechanisms by which probiotics exert their effects.

Main Methods:

  • Review of clinical trials and controlled studies on probiotic use.

Related Experiment Videos

  • Examination of different probiotic strains and their applications.
  • Analysis of proposed mechanisms of action for probiotic effects.

    • Main Results:

    • Saccharomyces boulardii and Lactobacillus rhamnosus GG are effective in preventing antimicrobial-associated diarrhea.
    • Probiotics show promise in treating Clostridium difficile-associated disease recurrences and various diarrheal conditions.
    • Lactobacillus species are effective for vaginal infections and are being studied for urinary-tract infections.

    Conclusions:

    • Probiotics can prevent and treat certain infections, potentially reducing antimicrobial exposure.
    • Mechanisms include pathogen inhibition, toxin neutralization, and immune stimulation.
    • Further controlled studies are necessary to fully establish the safety and efficacy of probiotics.